CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP
· Real-Time Price · USD
37.73
-0.94 (-2.43%)
At close: May 01, 2025, 3:59 PM
37.51
-0.60%
After-hours: May 01, 2025, 07:55 PM EDT
CRISPR Therapeutics Revenue
CRISPR Therapeutics reported an annual revenue of $35M, reflecting a -90.57% growth. For the quarter ending December 31, 2024, CRISPR Therapeutics generated $35M in revenue.
Revenue (ttm)
$35M
Revenue Growth
-90.57%
Price / Sales Ratio
94.87
Revenue / Employee
$89.06K
Employees
393
Market Cap
3.26B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 35M | -90.57% |
| Dec 31, 2023 | 371.21M | +85038.99% |
| Dec 31, 2022 | 436K | -99.95% |
| Dec 31, 2021 | 913.08M | +168054.88% |
| Dec 31, 2020 | 543K | n/a |